BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 1373518)

  • 1. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.
    Carter RH; Fearon DT
    Science; 1992 Apr; 256(5053):105-7. PubMed ID: 1373518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
    Fearon DT; Carter RH
    Annu Rev Immunol; 1995; 13():127-49. PubMed ID: 7542009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pillars Article: CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes. Science, 1992. 256: 105-107.
    Carter RH; Fearon DT
    J Immunol; 2010 Mar; 184(5):2233-5. PubMed ID: 20164433
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanisms.
    Smith SH; Rigley KP; Callard RE
    Immunology; 1991 Jul; 73(3):293-7. PubMed ID: 1715315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule.
    Engel P; Zhou LJ; Ord DC; Sato S; Koller B; Tedder TF
    Immunity; 1995 Jul; 3(1):39-50. PubMed ID: 7542548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice.
    Rickert RC; Rajewsky K; Roes J
    Nature; 1995 Jul; 376(6538):352-5. PubMed ID: 7543183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-receptors of B lymphocytes.
    O'Rourke L; Tooze R; Fearon DT
    Curr Opin Immunol; 1997 Jun; 9(3):324-9. PubMed ID: 9203413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion.
    Stamenkovic I; Seed B
    Nature; 1990 May; 345(6270):74-7. PubMed ID: 1691828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19.
    Vlasveld LT; Hekman A; Vyth-Dreese FA; Melief CJ; Sein JJ; Voordouw AC; Dellemijn TA; Rankin EM
    Cancer Immunol Immunother; 1995 Jan; 40(1):37-47. PubMed ID: 7530170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
    Chaouchi N; Vazquez A; Galanaud P; Leprince C
    J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperresponsive B cells in CD22-deficient mice.
    O'Keefe TL; Williams GT; Davies SL; Neuberger MS
    Science; 1996 Nov; 274(5288):798-801. PubMed ID: 8864124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell membrane characteristics of B-lymphocytes in chronic lymphocytic leukemia. II. Expression of B-cell markers].
    Pluta A; Górski A; Nowaczyk M
    Pol Arch Med Wewn; 1991 Sep; 86(3):154-8. PubMed ID: 1725559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antitumor activity of a chimeric anti-CD19 antibody.
    Pietersz GA; Wenjun L; Sutton VR; Burgess J; McKenzie IF; Zola H; Trapani JA
    Cancer Immunol Immunother; 1995 Jul; 41(1):53-60. PubMed ID: 7543822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antigen receptor affinity in T cell-independent antibody responses in vivo.
    Shih TA; Roederer M; Nussenzweig MC
    Nat Immunol; 2002 Apr; 3(4):399-406. PubMed ID: 11896394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD19/CD21 signal transduction complex of B lymphocytes.
    Tedder TF; Zhou LJ; Engel P
    Immunol Today; 1994 Sep; 15(9):437-42. PubMed ID: 7524521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [CD81 has a key role in B lymphocyte function].
    Smet J; van Zelm M; Schandené L; Adams B; van der Burg M; Mascart F
    Med Sci (Paris); 2011 Jan; 27(1):33-5. PubMed ID: 21299959
    [No Abstract]   [Full Text] [Related]  

  • 17. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
    Pezzutto A; Dörken B; Rabinovitch PS; Ledbetter JA; Moldenhauer G; Clark EA
    J Immunol; 1987 May; 138(9):2793-9. PubMed ID: 2437199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
    Nadler MJ; McLean PA; Neel BG; Wortis HH
    J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 20. Dual antigen recognition by B cells.
    van Noesel CJ; Lankester AC; van Lier RA
    Immunol Today; 1993 Jan; 14(1):8-11. PubMed ID: 7680204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.